{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:18:20Z","timestamp":1787883500436,"version":"build-2784847793"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011621","name":"Winship Cancer Institute of Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The eighth edition American Joint Committee on Cancer (AJCC) Staging incorporates significant changes to the seventh edition in the staging of oropharyngeal squamous cell carcinomas (OPSCC). An important change was the inclusion of OPSCC associated with the human papilloma virus (HPV). Our goal is to compare the performance of both staging systems for patients with HPV-selected and unselected clinical characteristics for OPSCC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using the Surveillance, Epidemiology, and End Results (SEER) database, 2004-2016, we identified patients with likely HPV-associated OPSCC based on surrogate markers (white males aged &amp;lt;65 years old with squamous cell carcinomas of the tonsil and base of tongue), excluding those who underwent surgery. We re-classified these patients using seventh and eighth edition staging for HPV-selected OPSCC and compared the prediction performance of both staging editions for overall survival (OS) and disease-specific survival (DSS). We performed the same analysis for clinically unselected patients with OPSCC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our analysis included 9554 patients with a median follow-up of 67 months. Comparing the eighth versus seventh edition for our HPV-selected cohort, clinical staging changed for 92.3% of patients and 10-year OS was 62.2%, 61.2%, 35.3%, and 15.5% for Stage I, II, III, and IV, versus 52.9%, 59.2%, 61.6%, 55.1%, 38.3%, and 15.5% for stage I, II, III, IVA, IVB, and IVC, respectively. A similar pattern was observed for 10-year DSS. The concordance statistics for our HPV-selected cohort were improved for both AJCC 7 (0.6260) and AJCC 8 (0.6846) compared with the unselected cohort, 0.5860 and 0.6457 for AJCC 7 and 8, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The overall performance of discrimination improved from AJCC 7 to AJCC 8 for both clinically selected and unselected patients, but more notably for our HPV-selected cohort. Despite the lack of statistically significant differentiation between Stages I and II in AJCC 8 in either groups, markedly improved discrimination was observed between Stages I\/II, III, and IV in the HPV-selected cohort.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyab001","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T05:00:52Z","timestamp":1641013252000},"page":"48-56","source":"Crossref","is-referenced-by-count":22,"title":["Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-8494","authenticated-orcid":false,"given":"Pooja","family":"Vijayvargiya","sequence":"first","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Rupji","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem S","family":"Kaka","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia Z","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stokes","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Steuer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong M","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Beitler","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA"},{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"},{"name":"Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir R","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Aiken","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil F","family":"Saba","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"33","key":"2022020822185391600_CIT0001","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human Papillomavirus-associated cancers - United States, 1999-2015.","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2022020822185391600_CIT0002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"32","key":"2022020822185391600_CIT0003","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"2022020822185391600_CIT0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000330807","article-title":"Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis.","volume":"81","author":"Saba","year":"2011","journal-title":"Oncology"},{"issue":"2","key":"2022020822185391600_CIT0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","article-title":"Epidemiologic trends in head and neck cancer and aids in diagnosis.","volume":"26","author":"Vigneswaran","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"4","key":"2022020822185391600_CIT0006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.","volume":"17","author":"O\u2019Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"2022020822185391600_CIT0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3322\/caac.21389","article-title":"Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2022020822185391600_CIT0008","first-page":"e33","article-title":"Emergence of a novel staging system for Oropharyngeal Squamous cell carcinoma based on HPV status.","volume":"31","author":"Panwar","year":"2017","journal-title":"Oncology (Williston Park)"},{"issue":"10","key":"2022020822185391600_CIT0009","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1055-9965.EPI-19-0038","article-title":"Incidence and demographic burden of HPV-associated Oropharyngeal head and neck cancers in the United States.","volume":"28","author":"Mahal","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"2022020822185391600_CIT0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer.","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncol"},{"issue":"5","key":"2022020822185391600_CIT0011","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3201\/eid2005.131311","article-title":"Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.","volume":"20","author":"Steinau","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2022020822185391600_CIT0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/adj.12652","article-title":"Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.","volume":"64","author":"Yakin","year":"2019","journal-title":"Aust Dent J"},{"issue":"8","key":"2022020822185391600_CIT0013","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hed.24764","article-title":"Morphologic and topographic radiologic features of human papillomavirus-related and -unrelated oropharyngeal carcinoma.","volume":"39","author":"Chan","year":"2017","journal-title":"Head Neck"},{"key":"2022020822185391600_CIT0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2020.04.027","article-title":"The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients.","volume":"134","author":"Zamani","year":"2020","journal-title":"Eur J Cancer"},{"issue":"2","key":"2022020822185391600_CIT0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.oraloncology.2009.11.004","article-title":"Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer.","volume":"46","author":"D\u2019Souza","year":"2010","journal-title":"Oral Oncol"},{"issue":"6","key":"2022020822185391600_CIT0016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/lio2.181","article-title":"Is HPV-associated oropharyngeal cancer becoming more common in older patients?","volume":"3","author":"Thompson","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"19","key":"2022020822185391600_CIT0017","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer.","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"2022020822185391600_CIT0018","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hed.20573","article-title":"Current topics in the epidemiology of oral cavity and oropharyngeal cancers.","volume":"29","author":"Gillison","year":"2007","journal-title":"Head Neck"},{"issue":"2","key":"2022020822185391600_CIT0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00428-017-2118-y","article-title":"HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist.","volume":"471","author":"Stevens","year":"2017","journal-title":"Virchows Arch"},{"issue":"8","key":"2022020822185391600_CIT0020","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/lary.28659","article-title":"Prognostic significance of smoking in Human Papillomavirus-positive Oropharyngeal cancer under American Joint Committee on Cancer eighth edition stage.","volume":"130","author":"Chidambaram","year":"2020","journal-title":"Laryngoscope"},{"key":"2022020822185391600_CIT0021","doi-asserted-by":"crossref","first-page":"1179550618792248","DOI":"10.1177\/1179550618792248","article-title":"How does smoking change the clinicopathological characteristics of human Papillomavirus-positive oropharyngeal squamous cell carcinoma? One medical center experience.","volume":"11","author":"Liu","year":"2018","journal-title":"Clin Med Insights Ear Nose Throat"},{"issue":"1","key":"2022020822185391600_CIT0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"2022020822185391600_CIT0023","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.12688\/f1000research.16866.1","article-title":"Carrying out streamlined routine data analyses with reports for observational studies: introduction to a series of generic SAS \u00ae macros.","volume":"7","author":"Liu","year":"2018","journal-title":"F1000Res"},{"key":"2022020822185391600_CIT0024","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.oraloncology.2018.06.024","article-title":"Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution.","volume":"83","author":"Gupta","year":"2018","journal-title":"Oral Oncol"},{"issue":"4","key":"2022020822185391600_CIT0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10147-017-1107-0","article-title":"Confirmation of the eighth edition of the AJCC\/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.","volume":"22","author":"Mizumachi","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"2022020822185391600_CIT0026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oraloncology.2017.01.002","article-title":"Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.","volume":"66","author":"Porceddu","year":"2017","journal-title":"Oral Oncol"},{"issue":"1","key":"2022020822185391600_CIT0027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12885-019-5894-8","article-title":"Validation of the 8th edition UICC\/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.","volume":"19","author":"van Gysen","year":"2019","journal-title":"BMC Cancer"},{"key":"2022020822185391600_CIT0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fonc.2017.00129","article-title":"Prognostic impact of AJCC\/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma.","volume":"7","author":"W\u00fcrdemann","year":"2017","journal-title":"Front Oncol"},{"key":"2022020822185391600_CIT0029","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.oraloncology.2017.08.020","article-title":"Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.","volume":"73","author":"Zhan","year":"2017","journal-title":"Oral Oncol"},{"issue":"1","key":"2022020822185391600_CIT0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cncr.32501","article-title":"Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?","volume":"126","author":"Yoshida","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"2022020822185391600_CIT0031","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2019.03.047","article-title":"Radiologic extranodal extension portends worse outcome in cN+ TNM-8 Stage I Human Papillomavirus-mediated oropharyngeal cancer.","volume":"104","author":"Billfalk-Kelly","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2022020822185391600_CIT0032","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated Oropharyngeal carcinoma (NRG Oncology HN002).","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"2022020822185391600_CIT0033","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/lary.28059","article-title":"Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.","volume":"130","author":"Bauer","year":"2020","journal-title":"Laryngoscope"},{"issue":"14","key":"2022020822185391600_CIT0034","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/cncr.30598","article-title":"The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.","volume":"123","author":"An","year":"2017","journal-title":"Cancer"},{"issue":"7","key":"2022020822185391600_CIT0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaoto.2016.0882","article-title":"Association of Extracapsular spread with survival according to human papillomavirus status in oropharynx squamous cell carcinoma and carcinoma of unknown primary site.","volume":"142","author":"Kharytaniuk","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2022020822185391600_CIT0036","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"key":"2022020822185391600_CIT0037","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41199-020-00058-2","article-title":"Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer.","volume":"5","author":"Khanna","year":"2020","journal-title":"Cancers Head Neck"},{"issue":"1","key":"2022020822185391600_CIT0038","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40463-018-0302-y","article-title":"The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.","volume":"47","author":"Liu","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"5","key":"2022020822185391600_CIT0039","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer.","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"S1","key":"2022020822185391600_CIT0040","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.21037\/cco.2018.12.01","article-title":"Recent changes in the American Joint Commission Cancer staging of human papilloma virus related oropharyngeal cancer: validating the present and envisioning the future.","volume":"8","author":"Miles","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"9","key":"2022020822185391600_CIT0041","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with medicare claims.","volume":"54","author":"Noone","year":"2016","journal-title":"Med Care"},{"key":"2022020822185391600_CIT0042","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"Amin","year":"2017"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/1\/48\/42379049\/oyab001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/1\/48\/42379049\/oyab001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T22:22:39Z","timestamp":1644358959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/27\/1\/48\/6516308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,28]]},"published-print":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyab001","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]}}}